Main Outcomes and Measures Revision surgery after an index septorhinoplasty was the main outcome measure, and the rate of revision was calculated within
subgroups of patients based on different demographic and clinical characteristics.
Not exact matches
Clinical features
of major depressive disorder (MDD) may help identify specific
subgroups of depressed
patients based on associations with genetic risk for major psychiatric disorders, reports a study in Biological Psychiatry.
The authors conclude that FL118 -
based therapy may be beneficial for a
subgroup of cancer
patients with tumors such as chronic lymphocytic leukemia and melanomas, in which MdmX overexpression confers treatment resistance.
To be able to evaluate the prognosis for individual
patients the disease is divided into
subgroups based on for example the presence or absence
of genetic alterations.
Little is known about the influence
of treatment techniques
based on DP on outcomes for
patients classified as high psychosocial risk using the
Subgroups for Targeted Treatment (STarT Back Screening Tool).
Clustering
based on unsupervised binary trees to define
subgroups of cancer
patients according to symptom severity in cancer.
This
subgroup of chronic depressed
patients represents 46.4 %
of the randomized sample in the parent study (cf. Keller et al. 2000), suggesting that chronically depressed individuals are less likely to be married than one would predict
based on marital status rates in the United States population (U.S. Census 1997).